SPREADING
HOPE
ONE STORY AT A TIME
-
Acute Lymphoblastic Leukaemia patient Kuldeep's Story
Kuldeep Dubey, a 44-year-old from Guna, Madhya Pradesh, was diagnosed with Ph-positive B-cell acute lymphoblastic leukemia. After relapsing following prior treatments, he topted for NexCAR19™ therapy during its Phase II clinical trials at Tata Memorial Centre in February 2023. On March 8, 2023, Kuldeep received NexCAR19™, a groundbreaking CAR-T therapy that offers a lifeline for patients with aggressive B-cell cancers. After just a short 7-day hospitalization, Kuldeep was discharged and declared to be in remission a month later. Fast forward to November 2024, Kuldeep continues to thrive, living a normal, healthy life with his family. NexCAR19™ provides a fighting chance for patients with limited options, offering personalized care and renewed hope. Now available in 80+ cities across India.
Acute Lymphoblastic Leukaemia patient Emily's Story
Emily Whitehead was diagnosed with acute lymphoblastic leukemia (ALL) at age five. In 2012, she became the first child in the world to receive CAR T-cell therapy in a breakthrough clinical trial.
She is considered cured now. She has start Emily Whitehead Foundation to support the cause further.
Lymphoma patient Richards's Story
Economics professor from Canterbury University, Richard Watt, 62 researched CAR-T therapy treatment availabilty oversees, as the time treatment was not available in New Zealand. Watt decided to travel to India to get the treatment.
Acute Lymphoblastic Leukaemia patient Pradeep's Story
Pradeep , a 26-year-old, was diagnosed with B-cell acute lymphoblastic leukemia in 2021. After facing a relapse despite prior treatments, he chose to take CAR-T treatment at Tata Memorial Centre in March 2024. Today, 11 months later, he remains in remission—an inspiring testament to the power of innovation in cancer treatment. NexCAR19™ offers renewed hope, personalized care, and a fighting chance for patients with limited treatment options.
Lymphomaa patient Muthhanna Ali's Story
After undergoing chemotherapy in Iraq, his doctors suggested he pursue more advanced treatment abroad. Initially, the recommendation was a bone marrow transplant. However, his journey took an unexpected and transformative turn in India, where he ultimately underwent CAR T-cell therapy, a revolutionary cancer treatment.